Aging
Navigate
Back to articleFigure 5(5 of 6)
100%
Figure 5
Figure 5.LDLRAD2 activates Wnt/β-catenin signaling pathway by targeting Axin1 in GC. Co-immunoprecipitation assay showed that LDLRAD2 could bind to Axin1 (A). LDLRAD2 inhibited Axin1 from binding to β-catenin (BC).